242 related articles for article (PubMed ID: 19826974)
61. The chemical, genetic and immunological basis of idiosyncratic drug-induced liver injury.
Tailor A; Faulkner L; Naisbitt DJ; Park BK
Hum Exp Toxicol; 2015 Dec; 34(12):1310-7. PubMed ID: 26614821
[TBL] [Abstract][Full Text] [Related]
62. Using genome-wide association studies to identify genes important in serious adverse drug reactions.
Daly AK
Annu Rev Pharmacol Toxicol; 2012; 52():21-35. PubMed ID: 21819236
[TBL] [Abstract][Full Text] [Related]
63. Minocycline hepatotoxicity: Clinical characterization and identification of HLA-B∗35:02 as a risk factor.
Urban TJ; Nicoletti P; Chalasani N; Serrano J; Stolz A; Daly AK; Aithal GP; Dillon J; Navarro V; Odin J; Barnhart H; Ostrov D; Long N; Cirulli ET; Watkins PB; Fontana RJ; ; ;
J Hepatol; 2017 Jul; 67(1):137-144. PubMed ID: 28323125
[TBL] [Abstract][Full Text] [Related]
64. Antituberculosis drug-induced hepatitis: risk factors, prevention and management.
Hussain Z; Kar P; Husain SA
Indian J Exp Biol; 2003 Nov; 41(11):1226-32. PubMed ID: 15332488
[TBL] [Abstract][Full Text] [Related]
65. HLA-B*5701 and flucloxacillin associated drug-induced liver disease.
Phillips EJ; Mallal SA
AIDS; 2013 Jan; 27(3):491-2. PubMed ID: 23291545
[No Abstract] [Full Text] [Related]
66. Genetic polymorphisms of CYP2C9 and CYP2C19 are not related to drug-induced idiosyncratic liver injury (DILI).
Pachkoria K; Lucena MI; Ruiz-Cabello F; Crespo E; Cabello MR; Andrade RJ;
Br J Pharmacol; 2007 Mar; 150(6):808-15. PubMed ID: 17279092
[TBL] [Abstract][Full Text] [Related]
67. Drug-induced cholestatic hepatitis from common antibiotics.
Med J Aust; 1992 Oct; 157(8):531. PubMed ID: 1479973
[No Abstract] [Full Text] [Related]
68. HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China.
Trachtenberg E; Vinson M; Hayes E; Hsu YM; Houtchens K; Erlich H; Klitz W; Hsia Y; Hollenbach J
Tissue Antigens; 2007 Dec; 70(6):455-63. PubMed ID: 17900288
[TBL] [Abstract][Full Text] [Related]
69. Hepatic adducts, circulating antibodies, and cytokine polymorphisms in patients with diclofenac hepatotoxicity.
Aithal GP; Ramsay L; Daly AK; Sonchit N; Leathart JB; Alexander G; Kenna JG; Caldwell J; Day CP
Hepatology; 2004 May; 39(5):1430-40. PubMed ID: 15122773
[TBL] [Abstract][Full Text] [Related]
70. Drug induced liver injury and its relationship to autoimmune hepatitis.
Weiler-Normann C; Schramm C
J Hepatol; 2011 Oct; 55(4):747-9. PubMed ID: 21396413
[No Abstract] [Full Text] [Related]
71. Antibiotic-induced liver toxicity: mechanisms, clinical features and causality assessment.
Robles M; Toscano E; Cotta J; Lucena MI; Andrade RJ
Curr Drug Saf; 2010 Jul; 5(3):212-22. PubMed ID: 20210729
[TBL] [Abstract][Full Text] [Related]
72. Genetics of drug-induced liver injury: Current knowledge and future prospects.
Daly AK
Clin Transl Sci; 2023 Jan; 16(1):37-42. PubMed ID: 36194091
[TBL] [Abstract][Full Text] [Related]
73. Inflammatory bowel disease: susceptibility and disease heterogeneity revealed by human leukocyte antigen genotyping.
Bouzid D; Kammoun A; Amouri A; Mahfoudh N; Haddouk S; Tahri N; Makni H; Masmoudi H
Genet Test Mol Biomarkers; 2012 Jun; 16(6):482-7. PubMed ID: 22224635
[TBL] [Abstract][Full Text] [Related]
74. HLA-B, -DRB1/3/4/5, and -DQB1 gene polymorphisms in human immunodeficiency virus-related Kaposi's sarcoma.
Dorak MT; Yee LJ; Tang J; Shao W; Lobashevsky ES; Jacobson LP; Kaslow RA
J Med Virol; 2005 Jul; 76(3):302-10. PubMed ID: 15902698
[TBL] [Abstract][Full Text] [Related]
75. Glutathione S-transferase m1 and t1 null genotypes increase susceptibility to idiosyncratic drug-induced liver injury.
Lucena MI; Andrade RJ; Martínez C; Ulzurrun E; García-Martín E; Borraz Y; Fernández MC; Romero-Gomez M; Castiella A; Planas R; Costa J; Anzola S; Agúndez JA;
Hepatology; 2008 Aug; 48(2):588-96. PubMed ID: 18666253
[TBL] [Abstract][Full Text] [Related]
76. Liver tumours, toxic hepatitis, intestinal failure-associated liver disease in children.
Lacaille F
Clin Res Hepatol Gastroenterol; 2012 Jun; 36(3):308-10. PubMed ID: 22537903
[TBL] [Abstract][Full Text] [Related]
77. HLA-B is the best candidate of susceptibility genes in HLA for Japanese ulcerative colitis.
Aizawa H; Kinouchi Y; Negoro K; Nomura E; Imai G; Takahashi S; Takagi S; Kakuta Y; Tosa M; Mochida A; Matsumura Y; Endo K; Shimosegawa T
Tissue Antigens; 2009 Jun; 73(6):569-74. PubMed ID: 19493234
[TBL] [Abstract][Full Text] [Related]
78. HLA-class II alleles in Egyptian patients with hepatocellular carcinoma.
El-Chennawi FA; Auf FA; Metwally SS; Mosaad YM; El-Wahab MA; Tawhid ZE
Immunol Invest; 2008; 37(7):661-74. PubMed ID: 18821214
[TBL] [Abstract][Full Text] [Related]
79. Diclofenac-induced liver injury: a paradigm of idiosyncratic drug toxicity.
Aithal GP
Expert Opin Drug Saf; 2004 Nov; 3(6):519-23. PubMed ID: 15500411
[TBL] [Abstract][Full Text] [Related]
80. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
